Head-to-head · WeighScore
Trimi vs yourEra
By GLP-1 ScorecardUpdated
Score comparison
Trimi has the higher recorded score — 86.4/100 to 83.8/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Trimi | yourEra |
|---|---|---|
| WeighScore | 86.4/100 | 83.8/100 |
| Grade | B | B |
| Site position | #9 | #7 |
| Semaglutide | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) | $89/mo (new-patient offer; confirm refill terms) |
| Tirzepatide | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) | $129/mo (new-patient offer; confirm refill terms) |
| Coverage | All 50 states | 50-state clinician network; treatment availability varies by state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #9 · B
Strengths
- Separate semaglutide and tirzepatide plans include prescribed medication and care
- Monthly, quarterly, six-month and annual charges published
- BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
- Supplies and shipping included under the published offer
What to consider
- Compounded injections only; no current branded or oral route
- Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
- Ordinary orders become nonrefundable once the prescription is issued, even before shipping
- A named pharmacy partner does not independently verify the pharmacy assigned to your order
Site position #7 · B
Strengths
- Public new-patient month-to-month prices; advertised same price across doses while active
- Evaluation, medication, injection supplies, dose management and shipping advertised together
- Terms name Thryv Telehealth by Lavin, P.C. and three potential dispensing pharmacies
- Free requested live visit; policy promises full refund if canceled before dispatch
What to consider
- Compounded formulations are not FDA-approved branded products
- Homepage price-continuation promise and terms allowing future refill price changes need reconciliation
- Optimum coaching, nutrition, at-home labs and wearables are coming soon, with no confirmed price or launch date
- Assessment usually asynchronous; prescription issuance triggers billing, and treatment availability varies by state
Featured provider
yourEra
yourEra scores 83.8/100 (B). Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.